Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656.

2.

PCR study of a series of ASCUS cases HPV-positive by HCII.

Alameda F, Bellosillo B, Lloveras B, Pairet S, Musset M, Pijuan L, Mariñoso L, Mancebo G, Larrazabal F, Carreras R, Serrano S.

Diagn Cytopathol. 2012 Dec;40(12):1043-6. doi: 10.1002/dc.21724. Epub 2011 Jun 7.

PMID:
21656701
3.

Human papillomavirus detection in urine samples: an alternative screening method.

Alameda F, Bellosillo B, Fusté P, Musset M, Mariñoso ML, Mancebo G, Lopez-Yarto MT, Carreras R, Serrano S.

J Low Genit Tract Dis. 2007 Jan;11(1):5-7.

PMID:
17194943
4.

Impact of a computerized information system on quality of nutritional support in the ICU.

Berger MM, Revelly JP, Wasserfallen JB, Schmid A, Bouvry S, Cayeux MC, Musset M, Maravic P, Chiolero RL.

Nutrition. 2006 Mar;22(3):221-9.

PMID:
16500548
5.

Two laminin receptors with N-acetylglucosamine-binding specificity.

Botti J, Musset M, Moutsita R, Aubery M, Derappe C.

Biochimie. 2003 Jan-Feb;85(1-2):231-9.

PMID:
12765792
6.

[Evaluation of the effect of pathology slide review on clinical practice in an oncology center].

Emile JF, Di Palma M, Musset M, Sebagh M, Auriault ML, Misset JL, Reynès M.

Ann Pathol. 2000 Sep;20(4):304-7. French.

PMID:
11015647
8.

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients.

Germann N, Brienza S, Rotarski M, Emile JF, Di Palma M, Musset M, Reynes M, Soulié P, Cvitkovic E, Misset JL.

Ann Oncol. 1999 Mar;10(3):351-4.

PMID:
10355582
9.

Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma in a child. Report of a case and review of the literature.

Lin BT, Musset M, Székely AM, Alexandre J, Fraitag S, Bodemer C, Charpentier A, Frenoy N, Misset JL, Medeiros LJ, Rappaport H.

Arch Pathol Lab Med. 1997 Dec;121(12):1282-6. Review.

PMID:
9431320
10.

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

Soulié P, Bensmaïne A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL, Cvitkovic E.

Eur J Cancer. 1997 Aug;33(9):1400-6.

PMID:
9337681
11.

Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

Brain E, Garrino C, Misset JL, Carbonero IG, Itzhaki M, Cvitkovic E, Goldschmidt E, Burki F, Regensberg C, Pappo E, Hagipantelli R, Musset M.

Br J Cancer. 1997;75(9):1360-7.

12.

Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.

Sapoval MR, Beyssen BM, Girardot C, Musset MA, Legmann P, Brekke O, Gaux JC.

Clin Radiol. 1996 Mar;51(3):210-3.

PMID:
8605753
13.

Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Kim-Triana B, Misset JL, Madelmont JC, Godenèche D, Musset M, Mathé G.

Anticancer Drugs. 1992 Jun;3(3):225-31.

PMID:
1525402
14.

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

Blazsek I, Musset M, Boulé D, Labat ML, Bringuier MF, Comisso M, Le Maignan C, Ribaud P, Mathé G, Misset JL.

Cancer Detect Prev. 1992;16(4):259-64.

PMID:
1458517
15.

Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

Blazsek I, Farabos C, Musset M, Goldschmidt E, Comisso M, Benavides M, Wang ZY, Labat ML, Mathé G, Misset JL.

Biomed Pharmacother. 1991;45(4-5):169-77.

PMID:
1932600
17.

Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.

Musset M, Mathé G, Reizenstein P.

Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):17-20.

PMID:
2663215
18.

Pulmonary sarcoidosis associated with Leydig cell testicular neoplasm.

Biglino A, Cariti G, Musset M, Gioannini P.

Chest. 1988 Aug;94(2):428-9.

PMID:
3396426
19.

Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.

Musset M, Mathé G, Reizenstein P.

Suppl J Med Oncol Tumor Pharmacother. 1988;1:17-20. No abstract available.

PMID:
3249552
20.

Supplemental Content

Loading ...
Support Center